Papers/PMID:41245414
The effect of long-term magnesium intake on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
Frontiers in nutrition2025The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
magnesium(2+) — no detected effect on tumour necrosis factor alpha concentration
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull result“For inflammatory parameters with fewer than 3 RCTs, magnesium supplementation showed no significant effects on serum IL-6 or tumor necrosis factor-alpha levels.”
Quoted verbatim from The effect of long-term magnesium intake on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- adults with metabolic syndrome or related insulin-resistant/diabetic conditions, oral magnesium supplementation for at least 2 months versus placebo (meta-analysis, fewer than 3 pooled RCTs for this analyte)
The effect of long-term magnesium intake on inflammatory markers in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.2025PMID:41245414Permalink